1800PetMeds® Press Releases

Call Us: 1-800-738-6337

Email Us

03.28.2001

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--March 28, 2001--PetMed Express, Inc. (OTCBB:PETS) today announced that it has hired Menderes Akdag as its Chief Executive Officer.

Mr. Akdag served as the Chief Executive Officer and a member of the Board of Director of International Cosmetics Marketing Co. dba Beverly Sassoon & Co. (OTCBB:ICMK), a direct sales marketing company distributing skin care and nutritional products, between November 2000 and March 2001. From May 1991 until August 2000, Mr. Akdag was employed by Lens Express, Inc., a direct sales company distributing replacement contact lens, serving as its President from May 1996 until August 2000, Chief Executive Officer and a member of the Board of Directors from August 1992 until May 1996, and Chief Financial Officer and a member of the Board of Directors from May 1991 until August 1992. Under the direction of Mr. Akdag, Lens Express' annual sales increased from $10 million to $48 million. Mr. Akdag holds a Bachelor of Science degree in Business Administration with a major in finance from the University of Florida where he graduated with high honors.

In conjunction with Mr. Akdag's appointment as CEO, Marc A. Puleo, M.D., Chairman of the Board of Directors and a founder of the company who had also been serving as CEO was elected President, and Christopher Lloyd, a member of the Board of Directors who had been serving as President and COO remains as the company's COO.

Dr. Marc Puleo stated, ``Mr. Akdag brings a wealth of experience from his nine-year affiliation with Lens Express, Inc. in the areas of sales, marketing and operations. We believe the breadth of Mr. Akdag's experience presents us with a unique opportunity to dramatically increase our growth. We look forward to Mr. Akdag playing a vital role in the continuing development and implementation of our strategic business plan.''

PetMed Express is America's largest pet pharmacy, specializing in the national sales of pet medications and pet health supplements.

This press release contains forward-looking statements, which involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward looking statements as a result of certain factors, including those set forth in PetMed Express' filings with the Securities and Exchange Commission.

Contact:
PetMed Express, Inc., Pompano Beach, Fla. Christopher Lloyd, 954/979-5995 ext. 8200 lloyd@petmedexpresst.com